News
- Ondine Announces VGH team Wins BC Quality Award for SSI Reduction Results Using Photodisinfection
PR Web – February 28 - In safer hands
North Shore News- January 22 - Reducing Surgical Site Infections With Photodisinfection
UCL Eastman Dental Institute- January 4 - Dr. Elizabeth Bryce Awarded Champion For Change Award For Integrating MRSAid into Vancouver General Hospital
PRWeb- December 31 - Light therapy cuts post-surgery infections at Vancouver General Hospital (with video)
Vancouver Sun – December 14 - Light therapy causes sharp drop in hospital infections
CBC News – December 13 - Ondine Biomedical’s MRSAID(TM) Technology Demonstrates Successful Results in Reducing Surgical Site Infections
PRWeb – December 12 - Being global in its DNA
Business without Borders – July 31 - MRSAid Photodisinfection Project Wins Innovation Award at Leading Canadian Infectious Disease & Microbiology Conference
May 08 - MRSAid(TM) Photodisinfection Data From Vancouver General Hospital Demonstrates Safety, Efficacy, and High Patient Compliance Rates
May 03 - Safety & Efficacy Benefits of Sinuwave Photodisinfection Therapy to be Presented at the National American Rhinologic Society Meeting
April 19 - Over 2500 Patients Treated at VGH Using the MRSAid™ Photodisinfection System
February 28 - In One Horrifying Moment, I Realized We Were About to Crash
Chatelaine Magazine – February
- Ondine Announces Ventilator Associated Pneumonia (VAP) Photodisinfection Clinical Study in the US
May 10 - Ondine to Participate in Vancouver General Hospital Infection Control Quality Improvement Project
April 15 - Dental Pioneer Professor Michael Wilson Speaking in Vancouver at Pacific Dental Conference
March 7 - Canadians Taking Action on Oral Health in Peru with Kindness in Action
January 31 - Vancouver Company Tackles Canada’s 4th Largest Killer
January 24 - UCL & Ondine Awarded £1 million by UK Medical Research Council to Develop Infection Prevention Technology for Catheters
January 18
- Ondine awarded QTDP Grant for Non-Antibiotic MRSA Decolonization Technology
November 4 - Ondine Completes Sale of Majority Interest in Sinusitis Subsidiary
September 15 - Ondine spinoff validates platform technology
July 20 - Ondine To Form Chronic Sinusitis Treatment Subsidiary
June 29 - Ondine Biopharma CEO Nominated for Manning Innovation Award
June 2 - FDA Accepts Filing of Ondine’s Pre-Market Approval (PMA) Application for Periowave™ Photodisinfection System
March 17 - Ondine Files PMA Submission For PeriowaveTM Photodisinfection System
January 7
- Ondine Announces Closing of Acquisition of Advanced Photodynamic Technologies, Inc.
December 8 - Ondine Announces Agreement to Acquire Advanced Photodynamic Technologies, Inc.
November 16 - Ondine Completes Sale of Dental Business
June 8 - Ondine Biopharma Enters into Letter of Intent for Sale of Dental Healthcare Business
April 8 - Ondine Expands MRSA Approvals with MRSAid Photodisinfection System
April 1 - Successful MRSA Wound Disinfection Study Announced by Ondine
Mar 12 - Ondine Biopharma Announces Management and Board Changes
Jan 7
- Ondine Announces Presentation of Positive Clinical Trial Results at the American Academy of Periodontology’s 94 Annual Meeting
September 5 - Ondine Announces FDA Confirmation of Regulatory Pathway for Periowave
August 27 - Ondine Announces Publication of Positive Results from Pseudomonas aeruginosa Eradication Study
August 7 - Ondine to Present at Canaccord Adams’ 28th Annual Global Growth Conference in Boston
August 6 - Ondine Announces Acquisition of Exclusive License fro Gold-Nanoparticle Photosensitizer
July 29 - Ondine Announces Periowave Presentation at IADR Annual Meeting
July 2 - Ondine Receives Health Canada License for Multi-Purpose Photodisinfection Laser
June 4 - Ondine Highlights Successful Multi-Centre Gum Disease Trial Outcomes at Vancouver Symposium
May 29 - Ondine Receives Health Canada License for the Treatment of Outer Ear Infections
May 26 - Ondine Announces Successful Outcome from Periowave Multi-Center Gum Disease Trial
May 7 - Periowave™ Gum Disease Treatment Studies to be Presented at AADR Annual Meeting
March 27 - Ondine’s Periowave Photodisinfection System Showcased at Pacific Dental Conference in Vancouver BC
March 7 - Ondine Announces Findings in Photodisinfection Treatment of MRSA to be Presented at the Society for General Microbiology’s 162nd Meeting in Scotland
March 6
- Ondine Provides Update On FDA Submission Process for its Periowave™ Photodisinfection System
December 20 - Ondine Demonstrates High Efficacy of Photodisinfection Technology Against Key Hospital Pathogen Pseudomonas aeruginosa
November 19 - Ondine Accelerates its MRSA Nasal Decolonization Program Following Reports of Complete Eradication in 5 Patients Without Use of Antibiotics
November 12 - Ondine Appoints Dr. Angelo Mariotti to Clinical Advisory Board
October 29 - University College London and Ondine Biopharma Announce Breakthrough Staphyloccocal Photodisinfection Technology
October 9 - Ondine Submits 510(k) Application to the FDA for Periowave™ Gum Disease Treatment System
October 1 - Data Demonstrating Efficacy of Periowave™ Photodisinfection Therapy for the Treatment of Gum Disease Presented at 12th Congress of the European Society of Photobiology
September 19 - Periowave Gum Disease Therapy: Positive Results from Meta-Analysis
September 10 - Ondine Announces Appointment of Dr. Timothy Rose as the Chairman of its Clinical Advisory Board
August 20 - Ondine to Present at CanaccordAdams Global Growth Conference
August 7 - Ondine’s Periowave™ Product Approved for Additional Indications in European Union
June 28 - Ondine to Present at The Needham & Company Biotechnology and Medical Technology Conference
June 13
- Ondine Announces Clinical Advisory Board Member is Recipient of the 2007 IADR Periodontal Disease Research Award
May 7 - Ondine Announces Consolidation of US Operations into New Bothell WA Facilities
April 18 - Ondine Announces Periowave™ Photodisinfection Data Published in the Journal of Clinical Dentistry
April 2 - Ondine demonstrates high Periowave™ efficacy in key tissue-invasive pathogen
March 23 - Revised Notice of AGM
March 22 - Notice of AGM
March 20 - MRSA Nasal Decolonization License Received from Health Canada
March 19 - Ondine Receives a Health Canada License for the use of Periowave to Treat Gingivitis
March 19 - Ondine Obtains Health Canada License for Peri-implantitis
February 15 - Ondine Reports Positive Results from its Third Consecutive Trial of Periowave™
February 6 - Ondine Announces Over 3,000 Patients Treated with Periowave™
January 29 - Notice of AGM
January 29 - Ondine Obtains Health Canada License for Endodontic Use
January 25 - Ondine Announces Positive Clinical Results from its Periowave™ Trial of Maintenance Therapy
January 22
